完整後設資料紀錄
DC 欄位語言
dc.contributor.authorSu, Chun-Linen_US
dc.contributor.authorChang, Chang-Chengen_US
dc.contributor.authorPeng, Yun-Shingen_US
dc.contributor.authorChen, Mei-Yenen_US
dc.date.accessioned2019-08-02T02:15:33Z-
dc.date.available2019-08-02T02:15:33Z-
dc.date.issued2018-12-01en_US
dc.identifier.issn0148-7043en_US
dc.identifier.urihttp://dx.doi.org/10.1097/SAP.0000000000001500en_US
dc.identifier.urihttp://hdl.handle.net/11536/152230-
dc.description.abstractObjective: The aim of this study is to investigate the preexisting predictive factors associated with comorbidities for diabetic foot ulcer (DFU) in King classification III at an outpatient clinic. Method: This prospective study included 100 patients with DFU in King classification III treated at outpatient clinics in Chiayi Chang Gung Memorial Hospital from January 2011 to December 2011. The least follow-up time was 1 year. Medical documentations were in respect of patient's baseline characteristics, associated history, presence of comorbidities, follow-up time, and condition of wounds. Patients were divided into success group (healed or healing with wound reduction), stagnate group, and failure group (amputation or infection, need in-hospitalmedical service) in accordance with the treatment response of wounds. chi(2) Test, Fisher exact test, and 1-way analysis of variance were used for variables in 3-group comparison, whereas Student t test was applied in 2-group comparison. The predictive factors with P value less than 0.1 were further investigated using the model of univariate logistic regression. Results: With 3-group stratification according to treatment response-failure (n = 8), stagnate (n = 22), and success (n = 70)-the occurrence rate of retinopathy was higher in the treatment stagnate group (42.1%) than in the treatment failure (14.3%) and success groups (12.5%; P = 0.019); the rate of previous percutaneous transluminal angioplasty (PTA) history was higher in the treatment failure group (25%) than in the treatment stagnate (4.8%) and success groups (1.5%; P = 0.020). With 2-group stratification-failure (n = 8) versus nonfailure (n = 92), and success (n = 70) versus nonsuccess (n = 30)-PTA history was strongly associated with treatment failure (odds ratio [OR], 14.33; 95% confidence interval [CI], 1.71-120.32; P = 0.014), whereas retinopathy (OR, 0.21; 95% CI, 0.07-0.65; P = 0.006) was the major negative predictor for treatment success. Previous debridement met borderline significance to predict treatment nonsuccess (OR, 0.09; 95% CI, 0.01-1.01; P = 0.051). Sex, age, associated history, dyslipidemia, hypertension, coronary artery disease, cerebrovascular accident, chronic kidney disease, and end-stage renal disease and wound condition had no statistical significance. Conclusions: Previous PTA and retinopathy, which indicated preexisting severe vasculopathy, are univariate predictive factors for treatment failure and nonsuccess, respectively, in patients with King classification III DFU. With the subdivision of King classification III DFU, medical history taking and fundus examination are acceptable methods for risk screening at an outpatient clinic.en_US
dc.language.isoen_USen_US
dc.subjectdiabetic foot ulcersen_US
dc.subjectcomorbidityen_US
dc.subjectKing classificationen_US
dc.subjectoutcomesen_US
dc.subjectoutpatienten_US
dc.titleThe Predictive Factors Associated With Comorbidities for Treatment Response in Outpatients With King Classification III Diabetes Foot Ulcersen_US
dc.typeArticleen_US
dc.identifier.doi10.1097/SAP.0000000000001500en_US
dc.identifier.journalANNALS OF PLASTIC SURGERYen_US
dc.citation.volume81en_US
dc.citation.spage0en_US
dc.citation.epage0en_US
dc.contributor.department影像與生醫光電研究所zh_TW
dc.contributor.departmentInstitute of Imaging and Biomedical Photonicsen_US
dc.identifier.wosnumberWOS:000473274100009en_US
dc.citation.woscount0en_US
顯示於類別:期刊論文